← All companies

RVMD

Revolution Medicines, Inc.

RVMDW Nasdaq Biological Products, (No Diagnostic Substances) EDGAR ↗

$8.84

-0.72 -7.58%

Key statistics

from XBRL data in SEC filings

Market cap

$1.88B

Revenue (TTM)

$0.00

Net income (TTM)

-$1.37B

EPS (TTM)

$-7.11

P/E ratio

—

Dividend yield

—

Free cash flow

-$914M

Cash

$441M

Total assets

$2.25B

Gross margin

—

52-week range

$8.80 – $9.34

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Director or officer change; Shareholder vote results Jun 22, 2026 10-Q Quarter ended 2026-03-31 May 6, 2026 8-K Results of operations (earnings release) May 6, 2026 8-K Entered a material agreement; Took on a direct financial obligation; Other events Apr 17, 2026 8-K Other events Apr 16, 2026 8-K Other events Apr 13, 2026 10-K Fiscal year ended 2025-12-31 Feb 25, 2026 8-K Results of operations (earnings release) Feb 25, 2026 10-Q Quarter ended 2025-09-30 Nov 5, 2025 8-K Results of operations (earnings release) Nov 5, 2025 8-K Other events Oct 17, 2025 8-K Other events Sep 10, 2025 10-Q Quarter ended 2025-06-30 Aug 6, 2025 8-K Results of operations (earnings release) Aug 6, 2025 8-K Shareholder vote results Jun 27, 2025 8-K Entered a material agreement; Took on a direct financial obligation; Regulation FD disclosure Jun 24, 2025 8-K Director or officer change Jun 18, 2025 10-Q Quarter ended 2025-03-31 May 7, 2025 8-K Results of operations (earnings release) May 7, 2025 10-K Fiscal year ended 2024-12-31 Feb 26, 2025 8-K Results of operations (earnings release) Feb 26, 2025 8-K Other events Dec 5, 2024 8-K Other events Dec 2, 2024 10-Q Quarter ended 2024-09-30 Nov 6, 2024 8-K Results of operations (earnings release) Nov 6, 2024 8-K Other events Oct 25, 2024 8-K Other events Oct 23, 2024 10-Q Quarter ended 2024-06-30 Aug 7, 2024 8-K Results of operations (earnings release); Director or officer change Aug 7, 2024 8-K Regulation FD disclosure; Other events Jul 15, 2024 8-K Shareholder vote results Jun 24, 2024 10-Q Quarter ended 2024-03-31 May 8, 2024 8-K Results of operations (earnings release) May 8, 2024 10-K Fiscal year ended 2023-12-31 Feb 26, 2024 8-K Results of operations (earnings release) Feb 26, 2024 8-K Results of operations (earnings release); Regulation FD disclosure Jan 9, 2024 8-K/A Dec 26, 2023 8-K Completed an acquisition or disposition; Director or officer change; Shareholder vote results; Regulation FD disclosure Nov 9, 2023 10-Q Quarter ended 2023-09-30 Nov 6, 2023 8-K Results of operations (earnings release) Nov 6, 2023